政策、产业、药企、AIDD、业绩等多重利好共振,四季度还看创新药?
❗ 全链布局创新药,关注T+0交易利器👇🏻
💊 港股通创新药ETF华宝#520880
🎯 100%布局创新药研发类公司
🧬 港股通医疗ETF华宝#159137
🎯CXO含量超50%


政策、产业、药企、AIDD、业绩等多重利好共振,四季度还看创新药?
❗ 全链布局创新药,关注T+0交易利器👇🏻
💊 港股通创新药ETF华宝#520880
🎯 100%布局创新药研发类公司
🧬 港股通医疗ETF华宝#159137
🎯CXO含量超50%


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.